Drug Shortage Report for PAPAVERINE HYDROCHLORIDE INJECTION USP
| Report ID | 179515 |
| Drug Identification Number | 00009881 |
| Brand name | PAPAVERINE HYDROCHLORIDE INJECTION USP |
| Common or Proper name | PAPAVERINE HYDROCHLORIDE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | PAPAVERINE HYDROCHLORIDE |
| Strength(s) | 65MG |
| Dosage form(s) | LIQUID |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 2ML |
| ATC code | A03AD |
| ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-12-21 |
| Estimated end date | 2023-03-10 |
| Actual end date | 2023-03-13 |
| Shortage status | Resolved |
| Updated date | 2023-03-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-03-14 | English | Compare |
| v6 | 2023-03-13 | French | Compare |
| v5 | 2023-03-13 | English | Compare |
| v4 | 2023-01-27 | French | Compare |
| v3 | 2023-01-27 | English | Compare |
| v2 | 2022-12-28 | French | Compare |
| v1 | 2022-12-28 | English | Compare |
Showing 1 to 7 of 7